Form 4: Beyond Air COO Michael Gaul Granted Stock Options
SEC Form 4 Filing
Michael A. Gaul, Chief Operating Officer of Beyond Air, Inc., was granted stock options to purchase 350,000 shares of common stock on March 20, 2024.
Summary
- On March 20, 2024, Michael A. Gaul, the Chief Operating Officer of Beyond Air, Inc. (XAIR), was granted stock options.
- These options allow him to purchase 350,000 shares of Beyond Air's common stock at an exercise price of $1.53 per share.
- The options vest in installments, starting with 25% on December 31, 2024, and the remainder vesting annually on December 31 for the following three years.
- The options expire on March 20, 2034.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a routine event, but it signals confidence in the company's future prospects and aligns management's interests with shareholders.
Positives
- The granting of stock options to the COO aligns his interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the COO.
Future Outlook
The document does not contain specific forward-looking statements regarding the company's future performance, but the granting of stock options suggests an expectation of future growth and value creation.
Industry Context
Stock options are a common form of executive compensation in the biotechnology industry, used to incentivize performance and align management's interests with those of shareholders. This grant is consistent with industry practices.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in the biotech industry.
- Companies like Amgen, Gilead, and Biogen routinely grant stock options to their executives.
- The vesting schedule and exercise price are typical for such grants, designed to incentivize long-term performance.
Stakeholder Impact
- Shareholders may view the stock option grant positively as it incentivizes the COO to improve company performance.
- Employees may see this as a sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 03/20/2024 | Date of earliest transaction (grant date of stock options) |
| 03/21/2024 | Date of Form 4 filing |
| 12/31/2024 | First vesting date for 25% of the stock options |
| 03/20/2034 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.